Emmanuelle Le Page
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Anti-CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non-Active Multiple Sclerosis.
Journal: Annals of clinical and translational neurology
Published: June 12, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Journal: Neurology
Published: May 05, 2026
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS.
Journal: Annals of clinical and translational neurology
Published: December 18, 2025
The Kappa Free Light Chains Index in Multiple Sclerosis: From Emerging Evidence to Clinical Application.
Journal: Journal of neurochemistry
Published: December 10, 2025
Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.
Journal: Brain : a journal of neurology
Published: October 13, 2025
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.
Journal: CNS drugs
Published: September 04, 2025
Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing-remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb.
Journal: Brain communications
Published: August 29, 2025
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Journal: JAMA neurology
Published: August 04, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France.
Journal: BMC neurology
Published: July 22, 2025
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis.
Journal: Brain : a journal of neurology
Published: July 21, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.
Journal: Neurology
Published: July 16, 2025
Non-inferiority of Rituximab versus OCrelizumab in Multiple Sclerosis (ROC-MS)-an individual participant data meta-analysis.
Journal: Multiple sclerosis and related disorders
Published: May 12, 2025
Last Updated: 09/26/2026